Exclusive articles:
Investing in Biotech: Why 2024 Could Be the Year of Major Gains
2024 sees a biotech rebound, with over 15 IPOs by mid-year and capital inflows increasing across the sector.
Gene therapy and oncology are driving biotech...
America’s Fight for Uranium Freedom: Will It Ever End?
The U.S. is actively working to reduce its reliance on foreign uranium, particularly from Russia, through domestic mining and strategic reserves.
Investment in advanced nuclear...
Bright Minds Targets Epilepsy with Breakthrough 5-HT2C Agonist
Bright Minds Biosciences launches a Phase 2 trial for BMB-101, targeting drug-resistant epilepsy with high unmet needs.
The company trades at a $5M market cap,...
Everything You Need to Know About the Stock Markets on 9/11
Asian markets face volatility due to rising oil prices and economic uncertainties, affecting key indices like Japan’s Nikkei and China’s Shanghai Composite.
Apple’s €13 billion...
Premier American Uranium is Advancing U.S. Uranium Projects for Future Growth
Premier holds significant uranium assets in New Mexico, Wyoming, and Colorado, positioning itself as a key player in the U.S. uranium market.
Positive drilling updates...
